moxonidine
Moxonidine is a new-generation centrally acting antihypertensive drug, which is approved for the treatment of mild to moderate essential hypertension. moxonidine has been shown to present blood pressure-independent beneficial effects on insulin resistance syndrome. Reference standards of Moxonidine API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Moxonidine impurity A (Y0000222)
[catalogue_number] => PA EPY0000222
[category_ids] => ,150,
[chemical_name] =>
[weight] => NA
[form] => NA
[cas] => NA
[pslug] => moxonidine-impurity-a-y0000222-paepy0000222
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Moxonidine impurity A (Y0000222)
stdClass Object
(
[pname] => Moxonidine (Y0000226)
[catalogue_number] => PA EPY0000226
[category_ids] => ,150,
[chemical_name] =>
[weight] => NA
[form] => NA
[cas] => NA
[pslug] => moxonidine-y0000226-paepy0000226
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)